Zilebesiran (Alnylam Pharmaceuticals), an investigational, subcutaneously administered small-interfering RNA (siRNA) therapeutic in development for the treatment of hypertension, met the primary and secondary endpoints, with an […]
It’s important to have counselors available for people diagnosed with clonal hematopoiesis of indeterminate potential (CHIP) or clonal cytopenia of undetermined significance (CCUS), according to medical […]
Hepatocellular carcinoma (HCC) etiologies differ “remarkably” by race/ethnicity, and the variation may warrant specific interventions for different populations, a new review suggests. HCC represents 78% of […]
COPENHAGEN — A novel, continuous levodopa/carbidopa (LD/CD) infusion appears to increase treatment on times among patients with Parkinson’s disease and improve clinician- and patient-rated outcomes, suggest […]
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.